TY - JOUR AU - Cugno, M. AU - Zanichelli, A. AU - Foieni, F. AU - Caccia, S. AU - Cicardi, M. PY - 2009 DA - 2009// TI - C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress JO - Trends Mol Med VL - 15 UR - https://doi.org/10.1016/j.molmed.2008.12.001 DO - 10.1016/j.molmed.2008.12.001 ID - Cugno2009 ER - TY - JOUR AU - Zuraw, B. L. AU - Christiansen, S. C. PY - 2009 DA - 2009// TI - Pathogenesis and laboratory diagnosis of hereditary angioedema JO - Allergy Asthma Proc VL - 30 UR - https://doi.org/10.2500/aap.2009.30.3277 DO - 10.2500/aap.2009.30.3277 ID - Zuraw2009 ER - TY - JOUR AU - Weiss, R. AU - Silverberg, M. AU - Kaplan, A. P. PY - 1986 DA - 1986// TI - The effect of C1 inhibitor upon Hageman factor autoactivation JO - Blood VL - 68 ID - Weiss1986 ER - TY - JOUR AU - Kaplan, A. P. AU - Joseph, K. AU - Silverberg, M. PY - 2002 DA - 2002// TI - Pathways for bradykinin formation and inflammatory disease JO - J Allergy Clin Immunol VL - 109 UR - https://doi.org/10.1067/mai.2002.121316 DO - 10.1067/mai.2002.121316 ID - Kaplan2002 ER - TY - JOUR AU - Fields, T. AU - Ghebrehiwet, B. AU - Kaplan, A. P. PY - 1983 DA - 1983// TI - Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin JO - J Allergy Clin Immunol VL - 72 UR - https://doi.org/10.1016/0091-6749(83)90052-0 DO - 10.1016/0091-6749(83)90052-0 ID - Fields1983 ER - TY - JOUR AU - Han, E. D. AU - MacFarlane, R. C. AU - Mulligan, A. N. AU - Scafidi, J. AU - Davis, A. E. PY - 2002 DA - 2002// TI - 3rd. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor JO - J Clin Invest VL - 109 UR - https://doi.org/10.1172/JCI200214211 DO - 10.1172/JCI200214211 ID - Han2002 ER - TY - JOUR AU - Nussberger, J. AU - Cugno, M. AU - Cicardi, M. AU - Cicardi, M. AU - Agostoni, A. PY - 1999 DA - 1999// TI - Local bradykinin generation in hereditary angioedema JO - J Allergy Clin Immunol VL - 104 UR - https://doi.org/10.1016/S0091-6749(99)70030-8 DO - 10.1016/S0091-6749(99)70030-8 ID - Nussberger1999 ER - TY - JOUR AU - Fernando, L. P. AU - Natesan, S. AU - Joseph, K. AU - Kaplan, A. P. PY - 2003 DA - 2003// TI - High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes JO - Thromb Haemost VL - 90 ID - Fernando2003 ER - TY - JOUR AU - Joseph, K. AU - Ghebrehiwet, B. AU - Kaplan, A. P. PY - 1999 DA - 1999// TI - Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells JO - Clin Immunol VL - 92 UR - https://doi.org/10.1006/clim.1999.4753 DO - 10.1006/clim.1999.4753 ID - Joseph1999 ER - TY - JOUR AU - Joseph, K. AU - Tholanikunnel, B. G. AU - Ghebrehiwet, B. AU - Kaplan, A. P. PY - 2004 DA - 2004// TI - Interaction of high molecular weight kininogen binding proteins on endothelial cells JO - Thromb Haemostasis VL - 91 ID - Joseph2004 ER - TY - JOUR AU - Schmaier, A. H. PY - 2008 DA - 2008// TI - Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system JO - Int Immunopharmacol VL - 8 UR - https://doi.org/10.1016/j.intimp.2007.08.022 DO - 10.1016/j.intimp.2007.08.022 ID - Schmaier2008 ER - TY - JOUR AU - Zhao, Y. AU - Qui, Q. AU - Mahdi, F. AU - Shariat-Madar, Z. AU - Rojkjaer, R. AU - Schmaier, A. H. PY - 2001 DA - 2001// TI - Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation JO - Am J Physiol VL - 280 ID - Zhao2001 ER - TY - JOUR AU - Bernstein, J. A. AU - Qazi, M. PY - 2010 DA - 2010// TI - Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability JO - Expert Rev Clin Immunol VL - 6 UR - https://doi.org/10.1586/eci.09.60 DO - 10.1586/eci.09.60 ID - Bernstein2010 ER - TY - JOUR AU - Vernon, M. K. AU - Rentz, A. M. AU - Wyrwich, K. W. AU - White, M. V. AU - Grienenberger, A. PY - 2009 DA - 2009// TI - Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema JO - Qual Life Res VL - 18 UR - https://doi.org/10.1007/s11136-009-9509-8 DO - 10.1007/s11136-009-9509-8 ID - Vernon2009 ER - TY - CHAP PY - 2010 DA - 2010// BT - Advisory Committee Briefing Document. Kalbitor® (ecallantide) For Acute Attacks of Hereditary Angioedema ID - ref15 ER - TY - CHAP AU - Horn, P. T. AU - Li, H. H. AU - Pullman, W. E. PY - 2010 DA - 2010// BT - Hypersensitivity reactions following ecallantide treatment for acute attacks of HAE. Presented at the American Academy of Allergy, Asthma, and Immunology ID - Horn2010 ER - TY - JOUR PY - 2004 DA - 2004// TI - HOE 140, JE 049, JE049 JO - Drugs R D VL - 5 UR - https://doi.org/10.2165/00126839-200405060-00006 DO - 10.2165/00126839-200405060-00006 ID - ref17 ER - TY - CHAP PY - 2010 DA - 2010// BT - CHMP Assessment Report For Firazyr ID - ref18 ER - TY - JOUR AU - Craig, T. AU - Riedl, M. AU - Dykewicz, M. S. PY - 2009 DA - 2009// TI - When is prophylaxis for hereditary angioedema necessary? JO - Ann Allergy Asthma Immunol VL - 102 UR - https://doi.org/10.1016/S1081-1206(10)60506-6 DO - 10.1016/S1081-1206(10)60506-6 ID - Craig2009 ER - TY - CHAP PY - 2010 DA - 2010// BT - CINRYZE (C1 Inhibitor) for routine prophylaxis against HAE attacks. Final clinical review ID - ref20 ER - TY - JOUR AU - Zuraw, B. AU - Yasothan, U. AU - Kirkpatrick, P. PY - 2010 DA - 2010// TI - Ecallantide JO - Nat Rev Drug Discov VL - 9 UR - https://doi.org/10.1038/nrd3125 DO - 10.1038/nrd3125 ID - Zuraw2010 ER - TY - JOUR AU - Craig, T. J. AU - Levy, R. J. AU - Wasserman, R. L. AU - Bewtra, A. K. AU - Hurewitz, D. PY - 2009 DA - 2009// TI - Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks JO - J Allergy Clin Immunol VL - 124 UR - https://doi.org/10.1016/j.jaci.2009.07.017 DO - 10.1016/j.jaci.2009.07.017 ID - Craig2009 ER - TY - CHAP AU - De Vries, S. PY - 2010 DA - 2010// BT - Pharming: Bio-Europe 2009 ID - De Vries2010 ER - TY - JOUR AU - Longhurst, H. PY - 2008 DA - 2008// TI - Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia JO - Curr Opin Investig Drugs VL - 9 ID - Longhurst2008 ER - TY - JOUR AU - Levi, M. AU - Choi, G. AU - Picavet, C. AU - Hack, C. E. PY - 2006 DA - 2006// TI - Self-administration of C1inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency JO - J Allergy Clin Immunol VL - 117 UR - https://doi.org/10.1016/j.jaci.2006.01.002 DO - 10.1016/j.jaci.2006.01.002 ID - Levi2006 ER - TY - JOUR AU - Bygum, A. AU - Andersen, K. E. AU - Mikkelsen, C. S. PY - 2009 DA - 2009// TI - Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits JO - Eur J Dermatol VL - 19 ID - Bygum2009 ER - TY - JOUR AU - Banerji, A. AU - Sloane, D. E. AU - Sheffer, A. L. PY - 2008 DA - 2008// TI - Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema JO - Ann Allergy Asthma Immunol VL - 100 UR - https://doi.org/10.1016/S1081-1206(10)60582-0 DO - 10.1016/S1081-1206(10)60582-0 ID - Banerji2008 ER -